In a story about quality-of-life assessments in cancer trials, Alyson Haslam, Ph.D., says: “The main goal of treating incurable cancers should be to lengthen the amount of time that people can survive. Sometimes, though, oncology drugs are approved on less important outcomes.”

A study led by Kevin Winthrop, M.D., M.P.H., found the live herpes zoster vaccine doesn’t provide reliable, long-term protection for rheumatoid arthritis patients who are taking tofacitinib.

Jeane-Marie Guise, M.D., M.P.H., says that women who have previously had a cesarean section do have a high chance of successful vaginal birth.

In a story about how endocrinologists are adjusting patient care during the pandemic, Maria Fleseriu, M.D., notes she can’t remotely care for patients with pituitary tumors and other urgent health care needs.

Next Level Burger is raising money to feed staff at OHSU and other hospitals.

An op-ed by Leslie Hammer, Ph.D. and Lindsey Alley, Ph.D., cites research that demonstrates the benefits of managers offering empathy toward their employees during the crisis.

Steven Baker, Ph.D., is a 2020 fellow of the Association for the Advancement for Medical Instrumentation.

Vijayshree Yadav, M.D., cites atrophy discovered in the brains and spinal cords of people with multiple sclerosis before they experience any other physical symptoms of the disease.

Selva Baltan, M.D., Ph.D., is a collaborator on research examining axon degeneration and its roll in neurodegenerative conditions such as Alzheimer’s disease.

Research from OHSU and others that characterized the antibodies in blood of COVID-19 patients was cited in a Sino Biological, Inc., press release.